Trial Profile
Seroprevalence, Multi-center, Phase IV Cross-sectional Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs Leptospirosis vaccine (Primary)
- Indications Leptospirosis
- Focus Therapeutic Use
- Sponsors Imaxio
- 07 May 2018 Status changed from recruiting to completed.
- 17 Apr 2018 New trial record